Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Osteoporosis 1Myocardial Ischemia 1Heart Diseases 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1Bone Diseases 1

Interventions

Zoledronic Acid 8Letrozole 7Risedronic Acid 6Vitamin D 4Absorptiometry, Photon 4Calcium 3Progesterone 2Hormone Replacement Therapy 2Cholecalciferol 2Calcium Carbonate 2Aromatase Inhibitors 2Anastrozole 2xian ling gu bao 1Testosterone 1Spectrum Analysis 1Raloxifene Hydrochloride 1Progestins 1Linseed Oil 1Exercise Movement Techniques 1Estrogens, Conjugated (USP) 1Estrogens 1Estrogen Replacement Therapy 1Estradiol 1Diphosphonates 1Dietary Supplements 1Diet, Fat-Restricted 1Denosumab 1Calcium Gluconate 1Calcium Citrate 1Bone Density 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteoporosis × Estrogen Replacement Therapy × Breast × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡